A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for the Prophylaxis of Migraine in Participants with Episodic Migraine Who Have Previously Failed 2 to 4 Classes of Oral Prophylactic Treatments (ELEVATE).

  • Hutton, Elspeth (Primary Chief Investigator (PCI))
  • Roos, Izanne (Chief Investigator (CI))

Project: Research

Project Details

Project Description

Protocol number 3101-304-002
Effective start/end date1/10/2031/10/23


  • Neuroscience
  • Migraine
  • Clinical trial